Innovative Companies Using Porcine-Derived Materials: Industry Spotlight on StemSys
At Sustainable Swine Resources (SSR), we’re proud to partner with companies that are pushing the boundaries of innovation through the thoughtful and sustainable use of porcine-derived materials. One standout example is StemSys, a regenerative medicine company that transforms underutilized porcine tissue into healing solutions that are helping thousands of patients across the U.S. from wound care to aesthetics, StemSys exemplifies how science and sustainability can come together to improve lives.
Who Is StemSys?
StemSys is a biotechnology company focused on regenerative medicine, specializing in the development of next-generation medical devices derived from naturally occurring bio-molecules found in porcine tissue. By extracting these molecules from tissue that would otherwise be discarded, StemSys is building a product line that’s not only effective but also aligned with modern sustainability goals.
What makes their approach unique is their use of a Multi-Tissue Platform (MTP™), which combines bio-molecules from various porcine tissue sources. This platform provides a broader spectrum of healing factors than single-tissue technologies, giving the body the natural signals it needs to regenerate and repair more completely.
Real-World Applications That Make a Difference
StemSys products have already impacted tens of thousands of patients across the country, many of whom are recovering from traumatic injuries, chronic wounds, and severe burns. These patients often face limited options and slow healing times, but the bioactive formulations developed by StemSys provide an environment that encourages the body’s own natural repair mechanisms to activate more effectively.
The company’s two FDA-cleared products—one in powder form and one in liquid form—are used in hospitals, wound care clinics, and surgical settings. The powder formulation is particularly well-suited for large or irregular wounds, while the liquid version offers flexibility for a range of clinical needs. Both are easy to apply and can integrate into existing treatment protocols.
Expanding into the Aesthetics Space
In addition to their presence in the medical field, StemSys is now extending their expertise into the aesthetic medicine market. Their liquid product is being used alongside cosmetic procedures, such as laser treatments, to enhance skin recovery and improve outcomes. The naturally derived biomolecules support skin rejuvenation by encouraging collagen production, improving skin texture, and promoting faster healing post-treatment.
This move into aesthetics represents a growing recognition of porcine-derived materials not only for clinical healing but also for cosmetic and wellness applications. It also reflects the growing trend of patients and providers seeking more natural, biologically compatible solutions in both medicine and aesthetics.
Partnering for a Better Future
At SSR, we’re proud to supply StemSys with high-quality porcine materials that meet their precise specifications. Through close collaboration, we help ensure their products are sourced responsibly, processed with care, and backed by the regulatory standards needed to succeed in highly controlled industries.
From sourcing and logistics to traceability and compliance, SSR is committed to helping companies like StemSys bring innovative ideas to market. We believe that when scientific discovery is paired with sustainable practices, everyone benefits—from patients and providers to the planet itself.
If your organization is developing products that rely on porcine tissue or biomaterials, connect with us to learn how we can support your goals.